These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 8806226)
1. Structure and biodistribution relationships of photodynamic sensitizers. Boyle RW; Dolphin D Photochem Photobiol; 1996 Sep; 64(3):469-85. PubMed ID: 8806226 [TBL] [Abstract][Full Text] [Related]
2. [History of photodynamic therapy--past, present and future]. Kato H Gan To Kagaku Ryoho; 1996 Jan; 23(1):8-15. PubMed ID: 8546474 [TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX. Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Dougherty TJ Lasers Surg Med; 2006 Jun; 38(5):439-44. PubMed ID: 16634075 [TBL] [Abstract][Full Text] [Related]
4. Cellular accumulation and biological activity of hematoporphyrin derivative(L) in comparison with photofrin II. Khanum F; Jain V Indian J Exp Biol; 1997 Apr; 35(4):348-55. PubMed ID: 9315233 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy in dermatology with porfimer sodium and benzoporphyrin derivative: an update. Lui H Semin Oncol; 1994 Dec; 21(6 Suppl 15):11-4. PubMed ID: 7992101 [TBL] [Abstract][Full Text] [Related]
9. Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Peng Q; Moan J; Nesland JM Ultrastruct Pathol; 1996; 20(2):109-129. PubMed ID: 8882357 [TBL] [Abstract][Full Text] [Related]
10. Subcellular localization of Photofrin and aminolevulinic acid and photodynamic cross-resistance in vitro in radiation-induced fibrosarcoma cells sensitive or resistant to photofrin-mediated photodynamic therapy. Wilson BC; Olivo M; Singh G Photochem Photobiol; 1997 Jan; 65(1):166-76. PubMed ID: 9066298 [TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy and some clinical applications in oncology. Dima VF; Ionescu MD; Balotescu C; Dima SF Roum Arch Microbiol Immunol; 2002; 61(3):159-205. PubMed ID: 14752983 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. Lilge L; Wilson BC J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099 [TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy for premalignant lesions in DMBA-treated hamsters: a preliminary study. Kingsbury JS; Cecere W; Mang TS; Liebow C J Oral Maxillofac Surg; 1997 Apr; 55(4):376-81; discussion 381-2. PubMed ID: 9120701 [TBL] [Abstract][Full Text] [Related]
14. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. O'Connor AE; Gallagher WM; Byrne AT Photochem Photobiol; 2009; 85(5):1053-74. PubMed ID: 19682322 [TBL] [Abstract][Full Text] [Related]
15. A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis. Nishie H; Kataoka H; Yano S; Kikuchi JI; Hayashi N; Narumi A; Nomoto A; Kubota E; Joh T Oncotarget; 2016 Nov; 7(45):74259-74268. PubMed ID: 27708235 [TBL] [Abstract][Full Text] [Related]
16. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models. Shi R; Li C; Jiang Z; Li W; Wang A; Wei J Molecules; 2017 Jan; 22(1):. PubMed ID: 28085075 [TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins. Gomer CJ; Ryter SW; Ferrario A; Rucker N; Wong S; Fisher AM Cancer Res; 1996 May; 56(10):2355-60. PubMed ID: 8625311 [TBL] [Abstract][Full Text] [Related]